US Patent Issued to JIANGSU TASLY DIYI PHARMACEUTICAL Co. on Feb. 24 for "CDK6/DYRK2 dual-target inhibitor, and preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,485, issued on Feb. 24, was assigned to JIANGSU TASLY DIYI PHARMACEUTICAL Co. LTD. (Huai'an, China).

"CDK6/DYRK2 dual-target inhibitor, and preparation method therefor and use thereof" was invented by Peng Yang (Nanjing, China), Haiping Hao (Nanjing, China), Yibei Xiao (Nanjing, China), Kai Yuan (Nanjing, China), Xiao Wang (Nanjing, China) and Wenbin Kuang (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention discloses a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof. The invention also discloses a preparation method of the compound and use thereof in preventing and/or t...